Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Phathom Pharmaceuticals Inc (NASDAQ: PHAT) was $6.55 for the day, up 5.14% from the previous closing price of $6.23. In other words, the price has increased by $5.14 from its previous closing price. On the day, 0.87 million shares were traded. PHAT stock price reached its highest trading level at $6.61 during the session, while it also had its lowest trading level at $6.13.
Ratios:
Our analysis of PHAT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.16 and its Current Ratio is at 4.20.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on February 14, 2025, initiated with a Overweight rating and assigned the stock a target price of $23.
On May 03, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $24.
Needham reiterated its Buy rating for the stock on January 05, 2024, while the target price for the stock was revised from $23 to $26.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 13 ’25 when Parikh Asit bought 10,000 shares for $4.42 per share. The transaction valued at 44,200 led to the insider holds 85,500 shares of the business.
Henderson Molly sold 6,583 shares of PHAT for $43,371 on Jan 21 ’25. The CFO and CBO now owns 93,546 shares after completing the transaction at $6.59 per share. On Jan 21 ’25, another insider, Nabulsi Azmi, who serves as the Chief Operating Officer of the company, sold 7,886 shares for $6.59 each. As a result, the insider received 51,957 and left with 233,390 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PHAT now has a Market Capitalization of 456122368 and an Enterprise Value of 713807040. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.26. Its current Enterprise Value per Revenue stands at 12.919 whereas that against EBITDA is -2.58.
Stock Price History:
The Beta on a monthly basis for PHAT is 0.37, which has changed by -0.37619048 over the last 52 weeks, in comparison to a change of 0.10838497 over the same period for the S&P500. Over the past 52 weeks, PHAT has reached a high of $19.71, while it has fallen to a 52-week low of $4.07. The 50-Day Moving Average of the stock is 10.99%, while the 200-Day Moving Average is calculated to be -40.54%.
Shares Statistics:
PHAT traded an average of 1.12M shares per day over the past three months and 1496650 shares per day over the past ten days. A total of 68.52M shares are outstanding, with a floating share count of 38.63M. Insiders hold about 44.53% of the company’s shares, while institutions hold 60.21% stake in the company. Shares short for PHAT as of 1740700800 were 13923473 with a Short Ratio of 12.48, compared to 1738281600 on 14630807. Therefore, it implies a Short% of Shares Outstanding of 13923473 and a Short% of Float of 28.65.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
